Medline Prices $2.13 Billion Secondary Offering of 60 Million Shares
Medline (MDLN) has announced the pricing of an underwritten secondary offering consisting of 60 million shares of its Class A common stock at $35.50 per share. The gross value of this secondary offering is approximately $2.13 billion, with the shares being sold by company affiliates. In a concurrent move to manage capital structure and support shareholder value, Medline is executing a $200 million share repurchase program alongside the offering. This dual-action approach balances the influx of new liquidity from the secondary sale with an active buyback strategy.

Tickers: $MDLN